Diabetes

Pharmacists are essential team members for the education of patients with diabetes, especially around injection technique for patients using injectable medications, such as insulin.

Omnipod 5 is the first tubeless automated insulin delivery system that integrates with the Dexcom G6 Continuous Glucose Monitoring System and a compatible smartphone.

For patients with type 1 and type 2 diabetes, decisions around the selection of glucose meters can be difficult as there are several brands and types of meters available.

These results suggest that maternal diet during pregnancy can significantly affect obesity risk in children.

Although fewer than 1 in 5 adults with type 2 diabetes are meeting targets to reduce heart disease risk, available therapies can help when combined with new approaches that barriers to care.

The FGF1 hormone regulates blood glucose by inhibiting fat breakdown, although it works differently than insulin.

Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.

In patients with gestational diabetes, there is a higher risk of developing type 2 diabetes.

These lumps can relate to the overproduction of hormones, including the stress steroid hormone cortisol, which can lead to T2D and high blood pressure.

This is an update to the 2011 AAN guideline on the treatment of painful diabetic neuropathy, according to a press release.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses her hopes for the future of SHC’s diabetes DRIVE program and its adoption within health systems.

Insulin glargine-yfgn (Semglee; Viatris) presents the first opportunity for retail pharmacists to dispense a biosimilar to patients.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses how the diabetes DRIVE program compares with the SHC DRIVE models for flu and COVID-19 vaccinations.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses what the SHC’s diabetes DRIVE toolkit is and how it helps to address disparities in diabetes disease burden and health outcomes.

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.

The data highlight a new role for pregnancy-associated plasma protein A, known as PAPP-A, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target, according to the investigators.

Prevalence of type 2 diabetes has been found higher in people with bipolar disorder, schizophrenia, and major depression compared to the general population.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity, addresses disparities occurring in diabetes care among racial and ethnic populations.

The new analysis includes approximately 1100 women without type 1 or type 2 diabetes (T2D) who subsequently gave birth at least once during the 25-year study period, which ended in 2011.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

The investigators analyzed an existing data set from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies, which included surveys on diet and exercise from a diverse patient population at 12 hospital centers across the United States.

Glipizide stimulates beta cells to produce more insulin in the body.

A panel of experts discusses diabetes treatment management and the impact pharmacists can have on an increasingly diverse patient population.

A more customized approach could be beneficial in terms of reducing illness via lifestyle and medication intervention monitoring.